Switching and its Impact on Perseveration in a Verbal Fluency Task: a Study in Persons With Alzheimer's Clinical Syndrome

被引:0
作者
Dubey, Neha [1 ,2 ]
Basu, Jayanti [1 ]
Pandey, Dinkar
Ghosh, Amitabha [2 ]
机构
[1] Univ Calcutta, Dept Appl Psychol, 92 Acharya Prafulla Chandra Rd, Kolkata 700009, India
[2] Apollo Multispecial Hosp Kolkata, Dept Neurol, 58 Canal Circular Rd, Kolkata 700054, India
关键词
Semantic fluency; Perseveration; Switching; Working memory; Alzheimer's disease; Mild cognitive impairment; WORKING-MEMORY; SEMANTIC FLUENCY; INHIBITORY CONTROL; CATEGORY FLUENCY; DISEASE SUBJECTS; DEMENTIA; INDIVIDUALS; HUNTINGTONS; IMPAIRMENT; INTRUSION;
D O I
10.1093/arclin/acaf007
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective The relationship between perseveration and switching in semantic verbal fluency tasks and the possible role of self-generated interference one must overcome before switching back to a previously visited subcategory has not been explored. Participants & Method We studied the performance on semantic verbal fluency in 60 cognitively unimpaired subjects, 30 patients with amnestic mild cognitive impairment (aMCI) and 30 patients with Alzheimer's Clinical Syndrome-dementia (ACS-Dementia). Our primary analysis focused on the association of switching and switchback with the first perseverative error. Results Perseveration was significantly associated with switchback in all three groups (chi 2 = 24.88, p < .001). Within-cluster perseverations were few. The number of switchbacks was the only significant variable to predict perseverative responses (p < .01). Moving from cognitively unimpaired to aMCI to ACS-Dementia, progressively fewer switches and switchbacks were needed to trigger perseveration. In over half of the perseverations after a switchback in the cognitively unimpaired and aMCI groups and in over a third in the ACS-Dementia group, the subjects had already activated a new word in the switched back subcategory. Conclusion Switching between subcategories and subsequent switchback play an important role in triggering perseverations in semantic verbal fluency tasks in the cognitively unimpaired as well as in aMCI and ACS-Dementia. Self-generated interference caused by repeated switching may overwhelm the working memory capacity enough to reactivate a previously suppressed response when revisiting an earlier subcategory. Our findings may facilitate a deeper understanding of the cognitive mechanisms underlying perseveration in semantic fluency tests.
引用
收藏
页数:9
相关论文
共 48 条
  • [41] Alzheimer's disease with sleep insufficiency: a cross-sectional study on correlations among clinical characteristics, orexin, its receptors, and the blood-brain barrier
    Guo, Peng
    Zhang, Wen-Jing
    Lian, Teng-Hong
    Zhang, Wei-Jiao
    He, Ming-Yue
    Zhang, Ya-Nan
    Huang, Yue
    Ding, Du-Yu
    Guan, Hui-Ying
    Li, Jing-Hui
    Li, Dan-Ning
    Luo, Dong-Mei
    Zhang, Wei-Jia
    Yue, Hao
    Wang, Xiao-Min
    Zhang, Wei
    NEURAL REGENERATION RESEARCH, 2023, 18 (08) : 1757 - 1762
  • [42] Impact of potential modifications to Alzheimer's disease clinical trials in response to disruption by COVID-19: a simulation study
    Schneider, Lon S.
    Qiu, Yuqi
    Thomas, Ronald G.
    Evans, Carol
    Jacobs, Diane M.
    Jin, Shelia
    Kaye, Jeffrey A.
    LaCroix, Andrea Z.
    Messer, Karen
    Salmon, David P.
    Sano, Mary
    Schafer, Kimberly
    Feldman, Howard H.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [43] Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)
    Richards, Kathy
    Morrison, Janet
    Wang, Yan-Yan
    Rangel, Angelica
    Loera, Ana
    Hanlon, Alexandra
    Lozano, Alicia
    Kovach, Christine
    Gooneratne, Nalaka
    Fry, Liam
    Allen, Richard
    RESEARCH IN GERONTOLOGICAL NURSING, 2020, 13 (06) : 280 - +
  • [44] The phenotypical core of Alzheimer's disease-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study
    Di Stefano, Francesca
    Kas, Aurelie
    Habert, Marie-Odile
    Decazes, Pierre
    Lamari, Foudil
    Lista, Simone
    Hampel, Harald
    Teichmann, Marc
    ALZHEIMERS & DEMENTIA, 2016, 12 (07) : 786 - 795
  • [45] Impact of therapeutic and low volume plasma exchange on clinical laboratory parameters in patients treated for Alzheimer's disease from the AMBAR study
    Grifols, Carlota
    Barcelo, Miquel
    Nunez, Laura
    Szczepiorkowski, Zbigniew M.
    Boada, Merce
    Lopez, Oscar L.
    Paez, Antonio
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (05) : 949 - 959
  • [46] Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study
    Hiroshi Matsuda
    Kyoji Okita
    Yumiko Motoi
    Toshiki Mizuno
    Manabu Ikeda
    Nobuo Sanjo
    Koji Murakami
    Taiki Kambe
    Toshiki Takayama
    Kei Yamada
    Takashi Suehiro
    Keiko Matsunaga
    Takanori Yokota
    Ukihide Tateishi
    Yoko Shigemoto
    Yukio Kimura
    Emiko Chiba
    Takahiro Kawashima
    Yui Tomo
    Hisateru Tachimori
    Yuichi Kimura
    Noriko Sato
    Annals of Nuclear Medicine, 2022, 36 : 1039 - 1049
  • [47] Evaluation of plasma amyloid peptides Aβ1-40 and Aβ1-42 as diagnostic biomarker of alzheimer's disease, its association with different grades of clinical severity and 18f-fluorodeoxyglucose positron emission tomography Z score in the Indian population: A case-control study
    Soni, Hariom
    Goyal, Manoj Kumar
    Sarma, Phulen
    Singh, Harmandeep
    Modi, Manish
    Sharma, Anchal
    Mohanty, Manju
    Vishnu, Venugopalan Y.
    Kumar, Ashok
    Mittal, Bhagwant Rai
    Medhi, Bikash
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2021, 36 (04): : 391 - 397
  • [48] Sex- and dose-dependent catalase increase and its clinical impact in a benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease
    Lane, Hsien-Yuan
    Wang, Shi-Heng
    Lin, Chieh-Hsin
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2024, 245